BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Ultimate Trader

1 year 40%, 2 years 50% and *3 years 60%

*Across 3 years $3395.52 only $1358.21

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,021.63
      0.57%
      US Tech 100
      20,367.60
      0.51%
      Dow Jones
      44,860.31
      0.28%
      Brent Oil
      72.325
      -0.17%
      Bitcoin
      93,151.08
      1.28%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Entrada Therapeutics Inc (TRDA)

      7. Entrada Therapeutics Inc (TRDA) Financials

      Entrada Therapeutics Inc

      Entrada Therapeutics Inc (TRDA)

      NASDAQ
      19.37
      0.33
      (1.73%)
      Closed November 27 4:00PM
      Delayed by 15 minutes
      19.37
      -0.01
      (-0.05%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      Statistics

      Annual Quarterly
      Year End December 30 2023 202120222023
      USD ($)USD ($)USD ($)
      Return on Assets (%) -33.455-33.919-1.854
      Return on Equity (%) -34.252-37.012-2.939
      Return on Invested Capital (%) -34.331-38.803-9.978
      Operating Margin (%) N/A N/A 9.345
      Net Profit Margin (%) N/A N/A -5.182
      Book Value Per Share 9.5676.777.263
      Earnings Per Share -1.638-3.014-0.2
      Cash Per Share 9.3221.4382.026
      Working Capital Per Share 9.3515.9856.323
      Operating Profit Per Share N/A N/A 3.866
      EBIT Per Share -1.638-3.0140.361
      EBITDA Per Share -1.638-3.0140.361
      Free Cash Flow Per Share -1.527-2.982-0.117

      Liquidity Ratios

      Year End December 30 2023 202120222023
      Current Ratio N/A N/A N/A
      Quick Ratio N/A N/A N/A
      Inventory Turnover (Days) N/A N/A N/A
      Shares Outstanding 31.22M31.4MN/A

      Key Stats and Ratios

      Year End December 30 2023 Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)
      Shares Outstanding N/A31.33M31.4MN/A33.21MN/AN/AN/A
      Return on Assets (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Return on Equity (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Return on Invested Capital (%) N/A N/A N/A N/A N/A N/A N/A N/A
      Operating Margin (%) N/A N/A N/A -12.363 N/A N/A N/A 42.84
      Net Profit Margin (%) N/A N/A N/A -26.421 N/A N/A N/A 39.743
      Sales Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Book Value Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Earnings Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Cash Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Working Capital Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Operating Profit Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      EBIT Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      EBITDA Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Free Cash Flow Per Share N/A N/A N/A N/A N/A N/A N/A N/A
      Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
      Quick Ratio N/A N/A N/A N/A N/A N/A N/A N/A
      Inventory Turnover (Days) N/A N/A N/A N/A N/A N/A N/A N/A

      Key Stats and Ratios

      Market Cap 712.48M
      Price to Earnings Ratio -108.51
      Price to Sales Ratio 5.62
      Price to Cash Ratio 10.73
      Price to Book Ratio 2.99
      Dividend Yield -

      Share Statistics

      Shares Outstanding 37.42M
      Average Volume (1 week) 86.42k
      Average Volume (1 Month) 136.4k
      52 Week Change 68.29%
      52 Week High 20.49
      52 Week Low 11.05
      More Ratios Coming Soon!

      Your Recent History

      NASDAQ
      TRDA
      Entrada Therapeutics
      Delayed Upgrade Clock